Armata Pharmaceuticals, Inc.
ARMP- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000921114
No open-market purchases or sales by Armata Pharmaceuticals, Inc. insiders were filed in the last 90 days; 53 institutions reported holding it in 13F filings for Q2 2026, worth $32.3M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Armata Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 17 | 20 | +3 |
| Shares | 1.32M | 1.35M | +29.8K (+2.2%) |
| Value | $7.25M | $6.61M | −$635.0K (−8.8%) |
New holders (4)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northern Trust Corp | 19,380 | $95.0K | 0.00% |
| Captrust Financial Advisors | 408 | $2.00K | 0.00% |
| FMR LLC | 285 | $1.00K | 0.00% |
| Salem Investment Counselors Inc | 100 | $0 | 0.00% |
Sold out (1)
Institutions that held Armata Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 12,032 | $66.0K |